VEGFR2/CD309 antibody (AA 1141-1190)
Quick Overview for VEGFR2/CD309 antibody (AA 1141-1190) (ABIN2889079)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1141-1190
-
Specificity
- VEGFR2 (Ab-1175) Antibody detects endogenous levels of total VEGFR2 protein.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human VEGFR2 (aa1141-1190).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IHC (1:50 - 1:100), Peptide-ELISA (1:20000), WB (1:500 - 1:1000)
Not recommended for: IHC-P -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR / VEGFR2
-
Background
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
Gene ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-